Valproic Acid: all 264 studies that test it
Page 2 of 3. Open to participants first (17), then studies with results posted, then the rest; newest registration first within each.
- Assessment of Valproate on Ethanol WithdrawalTerminatedNCT03235531Phase 4
- Sodium Valproate for GSDVCompletedNCT03112889Phase 2
- Phenobarbital Versus Valproate for Generalized Convulsive Status EpilepticusStatus unknownNCT03025906Phase 2
- The Optimal Treatment for Treatment-resistant SchizophreniaStatus unknownNCT02926976Not applicable
- A Dose Ranging Pilot Study for Intracerebroventricular (ICV) Delivery of Valproate in Subjects With Temporal SeizuresCompletedNCT02899611Phase 1/2
- Valproic Acid for Idiopathic Nephrotic SyndromeStatus unknownNCT02896270Phase 2/3
- A Study to Evaluate the Safety and Tolerability of Valproic Acid in Trauma Patients(Part 2)TerminatedNCT02872428Phase 1
- Valproic Acid With Methylprenisonlone for the Treatment of Acute GVHDStatus unknownNCT02848105Phase 2
- Influence of Valproic Acid on Extinction-based Therapy in Patients With Fear of Spiders.CompletedNCT02789813Phase 2
- Study of Cytolytic Viral Activation Therapy (CVAT) for Recurrent/Metastatic Nasopharyngeal CarcinomaStatus unknownNCT02761291Phase 1
- Stereotactic Radiosurgery With Nivolumab and Valproate in Patients With Recurrent GlioblastomaTerminatedNCT02648633Phase 1
- Valproic Acid Plus Cisplatin and Cetuximab in Recurrent and/or Metastatic Squamous Cell Carcinoma of Head and NeckStatus unknownNCT02624128Phase 2
- Chemoprevention of Head and Neck Squamous Cell Carcinoma (HNSCC) With Valproic AcidCompletedNCT02608736Early Phase 1
- Folate Receptor in Diagnosing Ovarian Cancer Using Serum Samples From Patients With Newly Diagnosed Pelvic Mass or Previously Diagnosed Ovarian CancerCompletedNCT02520115Phase 1
- Controlled Trial of Valproate Versus Risperidone in Young Children With Bipolar DisorderCompletedNCT02456454Phase 3
- Pharmacovigilance in Gerontopsychiatric PatientsTerminatedNCT02374567Phase 3
- Divalproex Sodium in the Treatment of the Cutaneous Manifestations of SclerodermaWithdrawnNCT02166229Phase 1/2
- Pretreatment With Valproate Prior to Immunotherapy Targeting Cluster of Differentiation Antigen 20 in Chronic Lymphocytic LeukemiaCompletedNCT02144623Early Phase 1
- Vidaza and Valproic Acid Post Allogeneic Transplant for High Risk AML and MDSStatus unknownNCT02124174Phase 2
- Treatment of Children With Autism Spectrum Disorders and Epileptiform EEG With Divalproex SodiumWithdrawnNCT02094651Phase 2
- Depakote (Divalproex Sodium) for Children With Temper Dysregulation and Severe Mood SwingsCompletedNCT02078596Phase 4
- Sunitinib Malate or Valproic Acid in Preventing Metastasis in Patients With High-Risk Uveal MelanomaActive, not recruitingNCT02068586Phase 2
- Traumatic Neuroprotection and Epilepsy Prevention of Valproate AcidStatus unknownNCT02027987Phase 1
- Pilot Trial of Valproate as Adjunctive Treatment for Toxoplasma Gondii Infection in Early Course SchizophreniaCompletedNCT02011750Phase 4
- A Study to Evaluate the Safety and Tolerability of Valproic Acid in Healthy Volunteers (Part 1)CompletedNCT01951560Phase 1
- A Study in Stable Epilepsy Patients Comparing Brand and Generic Divalproex Sodium Extended Release TabletsStatus unknownNCT01898676Phase 1
- Preoperative Valproic Acid and Radiation Therapy for Rectal CancerStatus unknownNCT01898104Phase 1/2
- Comparative Efficacy and Acceptability of Antimanic Drugs in Acute ManiaStatus unknownNCT01893229Phase 4
- Valproic Acid in Childhood Progressive Brain TumorsWithdrawnNCT01861990Phase 1
- Efficacy Study of Intravenous Sodium Valproate in Addition to First Line Anti Epileptic Treatment of Generalized Convulsive Status Epilepticus.CompletedNCT01791868Not applicable
- Haloperidol vs. Valproate in AgitationCompletedNCT01750541Phase 3
- Impact of Valproate on Angiogenesis and Histone Deacetylation in Bladder CancerCompletedNCT01738815Early Phase 1
- Treatment of Nodding Syndrome - A Randomized Blinded Placebo-Controlled Crossover Trial of Oral Pyridoxine and Conventional Anti-Epileptic Therapy, in Northern Uganda - 2012WithdrawnNCT01730313Phase 2
- Valproic Acid and Platinum-based Chemoradiation in Locally Advanced Head and Neck Squamous Cell CarcinomaCompletedNCT01695122Phase 2
- Valproate and Levocarnitine in Children With Spinal Muscular AtrophyStatus unknownNCT01671384Phase 3
- Valproate as First Line Therapy in Combination With Rituximab and CHOP in Diffuse Large B-cell LymphomaCompletedNCT01622439Phase 1/2
- Rubinstein-Taybi Syndrome: Functional Imaging and Therapeutic TrialCompletedNCT01619644Phase 2
- Efficacy of Quetiapine XR Versus Divalproex on Clinical Outcome Quality of Sleep and Quality of Life in Bipolar DepressionWithdrawnNCT01587066Phase 4
- Refractory Status Epilepticus Treatment StudyCompletedNCT01586208Phase 3
- Bioequivalence Study of Divalproex Sodium ER Tablets, 500 mg Under Fed ConditionsCompletedNCT01581788Phase 1
- Bioequivalence Study of Divalproex Sodium ER Tablets 500 mg of Dr. Reddy's Under Fasting ConditionsCompletedNCT01581775Phase 1
- Bevacizumab and Temsirolimus Alone or in Combination With Valproic Acid or Cetuximab in Treating Patients With Advanced or Metastatic Malignancy or Other Benign DiseaseTerminatedNCT01552434Phase 1
- The Efficacy and Safety of Topical Valproic Acid in Preventing Hair LossCompletedNCT01548066Phase 2
- Cytidine- and Creatine-Containing Drug in Treating Bipolar DepressionWithdrawnNCT01543139Phase 2
- A Study on the Effects of Valproate on the Pharmacokinetics of RO4917838 in Healthy VolunteersCompletedNCT01495104Phase 1
- Efficacy and Safety of Oral Valproic Acid for Retinitis PigmentosaCompletedNCT01399515Phase 2
- Valproic Acid With Chemoradiotherapy for Pancreatic CancerStatus unknownNCT01333631Phase 2
- Low Dose CdA Combined With Valproic Acid (VPA) in Previously Treated B-cell Chronic Lymphocytic Leukemia(B-CLL)Status unknownNCT01295593Phase 1/2
- Temsirolimus and Valproic Acid in Treating Young Patients With Relapsed Neuroblastoma, Bone Sarcoma, or Soft Tissue SarcomaTerminatedNCT01204450Phase 1
- Valproic Acid With Chemoradiotherapy for Non-Small-Cell Lung CancerStatus unknownNCT01203735Phase 1/2
- A Study of Divalproex Sodium in Children With ASD and Epileptiform EEGWithdrawnNCT01170325Phase 2
- Bioequivalence Study of Divalproex Sodium DR Tablets 500 mg of Dr. Reddy's Under Fed ConditionsCompletedNCT01132196Phase 1
- Bioequivalence Study of Divalproex Sodium Capsules(Sprinkle),125 mg of Dr. Reddy's Under Fasting Condition (Apple Sauce)CompletedNCT01132183Phase 1
- Bioequivalency Study of Divalproex Sodium DR Tablets, 500 mg of Dr.Reddy's Under Fasting ConditionsCompletedNCT01132170Phase 1
- Seizures Post Intracerebral HemorrhageCompletedNCT01115959Phase 4
- Bevacizumab, Chemotherapy and Valproic Acid in Advanced SarcomasCompletedNCT01106872Phase 1
- A Drug Interaction Study of Valproic Acid and Paliperidone Extended-Release (ER) in Patients With Schizophrenia, Bipolar I Disorder, or Schizoaffective DisorderCompletedNCT01094249Phase 1
- Safety Study of Depakote Versus Lithium in African Americans With Bipolar DisorderWithdrawnNCT01075126Phase 4
- Pharmacokinetic Interactions in Combination Treatment of Valproic Acid and Ertapenem in Normal SubjectsCompletedNCT01073059Phase 1
- A Drug Interaction Study of Valproic Acid and Single-dose Paliperidone Extended-Release (ER) in Healthy MenCompletedNCT01060228Phase 1
- Bioequivalence Study of Dr. Reddy's Divalproex Sodium Coated Particles in Capsules, 125 mg, Under Fed ConditionCompletedNCT01056627Phase 1
- Bioequivalence Study of Dr. Reddy's Divalproex Sodium Capsules (Sprinkle), 125 mg Under Fasting ConditionsCompletedNCT01055938Phase 1
- Valproic Acid in Treating Patients With Previously Treated Non-Hodgkin Lymphoma, Hodgkin Lymphoma, or Chronic Lymphocytic LeukemiaStatus unknownNCT01016990Phase 2
- Adjuvant Valproate for High Grade SarcomasTerminatedNCT01010958Phase 1
- Molecular Signature of Valproic Acid in Breast Cancer With Functional Imaging Assessment - a PilotTerminatedNCT01007695Phase 1
- Disease Stabilization in AML by Treatment With ATRA, Valproic Acid and Low-dose CytarabineCompletedNCT00995332Phase 1/2
- Divalproex Sodium 500 mg Extended Release Tablets Under Fasting ConditionsCompletedNCT00974441Phase 1
- Divalproex Sodium 500 mg Extended Release Tablets Under Non-Fasting ConditionsCompletedNCT00974012Phase 1
- To Demonstrate the Relative Bioavailability of Divalproex Sodium 500 mg Delayed Release Tablets Under Fasting ConditionsCompletedNCT00913874Phase 1
- To Demonstrate the Relative Bioavailability of Divalproex Sodium 500 mg Delayed Release Tablets Under Fed ConditionsCompletedNCT00913848Phase 1
- Study of Decitabine Alone or in Combination With Valproic Acid and All-trans Retinoic Acid in Acute Myeloid LeukemiaCompletedNCT00867672Phase 2
- Bioequivalence Study of Divalproex Sodium 125 MG Delayed Release Tablets Under Fasting ConditionsCompletedNCT00864006Phase 1
- Study of Efficacy and Safety of Valproic Acid in Chronic Lymphocytic Leukemia (CLL)Status unknownNCT00810680Not applicable
- A Phase II Study of Doxorubicin, Cyclophosphamide and Vindesine With Valproic Acid in Patients With Refractory or Relapsing Small Cell Lung Cancer After Platinum Derivatives and EtoposideCompletedNCT00759824Phase 2
- Comparing The Effect On Cognition Of Adjunctive Therapy With Zonisamide Versus Sodium ValproateCompletedNCT00713622Phase 4
- Use Of Valproid Acid To Treat Tropical Spastic Paraparesis/HTLV-1-Associated Myelopathy (TSP/HAM)CompletedNCT00681980Phase 3
- Food Study of Divalproex Sodium Extended-Release Tablets 500 mg to Depakote ER® Tablets 500 mgCompletedNCT00648076Phase 1
- Fasting Study of Divalproex Sodium Extended-Release Tablets 500 mg to Depakote ER® Tablets 500 mgCompletedNCT00647712Phase 1
- Pediatric Switch Study for Children and Adolescent Patients With EpilepsyCompletedNCT00646711Phase 2
- Phase II Study of Valproate and Doxorubicin in Malignant MesotheliomaCompletedNCT00634205Phase 2
- The Effect of Valproate on Benzodiazepine Withdrawal SeverityCompletedNCT00570219Not applicable
- Effectiveness of Lithium and Valproate in Treating High-Risk Bipolar DisorderCompletedNCT00563992Phase 1
- Effects of Atypical Antipsychotic and Valproate Combination Therapy on Glucose and Lipid Metabolism in SchizophreniaCompletedNCT00552500Not applicable
- Abilify in Bipolar Disorder for 6 Weeks Treatment EffectivenessCompletedNCT00545142Phase 4
- Hydralazine Valproate for Ovarian CancerStatus unknownNCT00533299Phase 3
- Hydralazine Valproate for Cervical CancerStatus unknownNCT00532818Phase 3
- Valproic Acid and Bevacizumab in Patients With Advanced CancerCompletedNCT00530907Phase 1
- Azacitidine and Valproic Acid Plus Carboplatin in Patients With Ovarian CancerCompletedNCT00529022Phase 1
- HDAC Inhibitor Valproic Acid as an Effective Therapy for Chronic Lymphocytic LeukemiaTerminatedNCT00524667Phase 2
- Safety and Efficiency Study of Valproic Acid In HAM/TSPTerminatedNCT00519181Not applicable
- Valproate and Etoposide for Patients With Neuronal Tumors and Brain MetastasesCompletedNCT00513162Phase 1
- Azacytidine and Valproic Acid in Patients With Advanced CancersCompletedNCT00496444Phase 1
- Valproic Acid in Ambulant Adults With Spinal Muscular AtrophyCompletedNCT00481013Phase 2
- Phase I Study of Temozolomide, Valproic Acid and Radiation Therapy in Patients With Brain MetastasesTerminatedNCT00437957Phase 1
- Valproic Acid Sodium Salt in Bipolar DisorderCompletedNCT00431522Phase 4
- A Phase II Study of Epigenetic Therapy to Overcome Chemotherapy Resistance in Refractory Solid TumorsCompletedNCT00404508Phase 2
- Hydralazine and Valproate Plus Cisplatin Chemoradiation in Cervical CancerCompletedNCT00404326Phase 2
- Trial of Valproic Acid in Patients With Progressive Supranuclear Palsy (Depakine)CompletedNCT00385710Phase 2
- Safety and Efficacy of Divalproex and Quetiapine in Elderly Alzheimer's Dementia PatientsWithdrawnNCT00375557Phase 4
- Study of Safety and Dosing Effect on SMN Levels of Valproic Acid (VPA) in Patients With Spinal Muscular AtrophyCompletedNCT00374075Phase 1